make WWAY your homepage  Become a fan on facebook  Follow us on twitter  Receive RSS Newsfeeds  MEMBERS: Register | Login

FDA expands use of Abbott Labs' neck stent


WASHINGTON (AP) -- Federal health officials have expanded approval of an artery-opening stent from Abbott Laboratories to a larger group of patients at risk for stroke caused by plaque in the neck arteries.

The Food and Drug Administration said it approved the Acculink stent for patients who are at moderate risk of complications if they underwent the alternative surgical procedure. The procedure, known as an endarterectomy, involves cutting open the neck artery and scraping out plaque formations that can block blood flow.

Previously Acculink was only approved for patients at high risk for complications if they underwent surgery.

Stents are mesh-metal tubes used to hold open arteries where plaque is beginning to form. They are threaded up into the artery with a catheter through a small incision made in the groin.

(Copyright 2011 by The Associated Press. All Rights Reserved.)

Disclaimer: Comments posted on this, or any story are opinions of those people posting them, and not the views or opinions of WWAY NewsChannel 3, its management or employees. You can view our comment policy here.



The content of this field is kept private and will not be shown publicly.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.

More information about formatting options

To prevent automated spam submissions leave this field empty.
Please re-enter the code shown in the image below.